QQQ   361.26 (+0.83%)
AAPL   173.75 (+1.48%)
MSFT   321.80 (+1.92%)
META   306.82 (+2.20%)
GOOGL   134.17 (+2.53%)
AMZN   129.46 (+1.84%)
TSLA   251.60 (+0.55%)
NVDA   447.82 (+2.95%)
NIO   8.79 (-2.77%)
BABA   86.53 (-0.24%)
AMD   103.27 (+0.44%)
T   14.67 (-2.33%)
F   12.31 (-0.97%)
MU   67.96 (-0.10%)
CGC   0.74 (-6.35%)
GE   108.79 (-1.59%)
DIS   81.67 (+0.76%)
AMC   8.16 (+2.00%)
PFE   33.94 (+2.32%)
PYPL   58.56 (+0.17%)
NFLX   380.33 (+0.72%)
QQQ   361.26 (+0.83%)
AAPL   173.75 (+1.48%)
MSFT   321.80 (+1.92%)
META   306.82 (+2.20%)
GOOGL   134.17 (+2.53%)
AMZN   129.46 (+1.84%)
TSLA   251.60 (+0.55%)
NVDA   447.82 (+2.95%)
NIO   8.79 (-2.77%)
BABA   86.53 (-0.24%)
AMD   103.27 (+0.44%)
T   14.67 (-2.33%)
F   12.31 (-0.97%)
MU   67.96 (-0.10%)
CGC   0.74 (-6.35%)
GE   108.79 (-1.59%)
DIS   81.67 (+0.76%)
AMC   8.16 (+2.00%)
PFE   33.94 (+2.32%)
PYPL   58.56 (+0.17%)
NFLX   380.33 (+0.72%)
QQQ   361.26 (+0.83%)
AAPL   173.75 (+1.48%)
MSFT   321.80 (+1.92%)
META   306.82 (+2.20%)
GOOGL   134.17 (+2.53%)
AMZN   129.46 (+1.84%)
TSLA   251.60 (+0.55%)
NVDA   447.82 (+2.95%)
NIO   8.79 (-2.77%)
BABA   86.53 (-0.24%)
AMD   103.27 (+0.44%)
T   14.67 (-2.33%)
F   12.31 (-0.97%)
MU   67.96 (-0.10%)
CGC   0.74 (-6.35%)
GE   108.79 (-1.59%)
DIS   81.67 (+0.76%)
AMC   8.16 (+2.00%)
PFE   33.94 (+2.32%)
PYPL   58.56 (+0.17%)
NFLX   380.33 (+0.72%)
QQQ   361.26 (+0.83%)
AAPL   173.75 (+1.48%)
MSFT   321.80 (+1.92%)
META   306.82 (+2.20%)
GOOGL   134.17 (+2.53%)
AMZN   129.46 (+1.84%)
TSLA   251.60 (+0.55%)
NVDA   447.82 (+2.95%)
NIO   8.79 (-2.77%)
BABA   86.53 (-0.24%)
AMD   103.27 (+0.44%)
T   14.67 (-2.33%)
F   12.31 (-0.97%)
MU   67.96 (-0.10%)
CGC   0.74 (-6.35%)
GE   108.79 (-1.59%)
DIS   81.67 (+0.76%)
AMC   8.16 (+2.00%)
PFE   33.94 (+2.32%)
PYPL   58.56 (+0.17%)
NFLX   380.33 (+0.72%)
NASDAQ:NERV

Minerva Neurosciences (NERV) Competitors

$6.69
-0.21 (-3.04%)
(As of 10/2/2023 ET)
Compare
Today's Range
$6.60
$6.97
50-Day Range
$6.69
$10.52
52-Week Range
$1.26
$14.70
Volume
6,355 shs
Average Volume
402,013 shs
Market Capitalization
$46.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$11.00

NERV vs. RMTI, VTGN, HOOK, RZLT, DNTH, CLSD, MEIP, IPA, SLS, and VTVT

Should you be buying Minerva Neurosciences stock or one of its competitors? The main competitors of Minerva Neurosciences include Rockwell Medical (RMTI), Vistagen Therapeutics (VTGN), Hookipa Pharma (HOOK), Rezolute (RZLT), Dianthus Therapeutics (DNTH), Clearside Biomedical (CLSD), MEI Pharma (MEIP), ImmunoPrecise Antibodies (IPA), SELLAS Life Sciences Group (SLS), and vTv Therapeutics (VTVT). These companies are all part of the "pharmaceutical preparations" industry.

Minerva Neurosciences vs.

Rockwell Medical (NASDAQ:RMTI) and Minerva Neurosciences (NASDAQ:NERV) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their community ranking, dividends, profitability, media sentiment, institutional ownership, risk, analyst recommendations, earnings and valuation.

Minerva Neurosciences has a net margin of 0.00% compared to Minerva Neurosciences' net margin of -15.32%. Rockwell Medical's return on equity of 0.00% beat Minerva Neurosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Rockwell Medical-15.32% -88.74% -25.89%
Minerva Neurosciences N/A N/A -45.87%

22.1% of Rockwell Medical shares are owned by institutional investors. Comparatively, 55.1% of Minerva Neurosciences shares are owned by institutional investors. 2.2% of Rockwell Medical shares are owned by company insiders. Comparatively, 6.4% of Minerva Neurosciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Rockwell Medical has higher revenue and earnings than Minerva Neurosciences. Rockwell Medical is trading at a lower price-to-earnings ratio than Minerva Neurosciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Rockwell Medical$72.81M0.79-$18.68M-$0.88-2.31
Minerva Neurosciences$41.18M1.15-$32.11M-$4.98-1.36

Rockwell Medical currently has a consensus price target of $11.00, indicating a potential upside of 439.22%. Minerva Neurosciences has a consensus price target of $11.00, indicating a potential upside of 62.96%. Given Minerva Neurosciences' stronger consensus rating and higher probable upside, research analysts plainly believe Rockwell Medical is more favorable than Minerva Neurosciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Rockwell Medical
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Minerva Neurosciences
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Minerva Neurosciences received 50 more outperform votes than Rockwell Medical when rated by MarketBeat users. Likewise, 62.08% of users gave Minerva Neurosciences an outperform vote while only 57.34% of users gave Rockwell Medical an outperform vote.

CompanyUnderperformOutperform
Rockwell MedicalOutperform Votes
297
57.34%
Underperform Votes
221
42.66%
Minerva NeurosciencesOutperform Votes
347
62.08%
Underperform Votes
212
37.92%

In the previous week, Rockwell Medical had 5 more articles in the media than Minerva Neurosciences. MarketBeat recorded 7 mentions for Rockwell Medical and 2 mentions for Minerva Neurosciences. Minerva Neurosciences' average media sentiment score of 0.69 beat Rockwell Medical's score of 0.63 indicating that Rockwell Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Rockwell Medical
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Minerva Neurosciences
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Rockwell Medical has a beta of 1.4, meaning that its share price is 40% more volatile than the S&P 500. Comparatively, Minerva Neurosciences has a beta of 0.25, meaning that its share price is 75% less volatile than the S&P 500.

Summary

Rockwell Medical beats Minerva Neurosciences on 10 of the 18 factors compared between the two stocks.


Get Minerva Neurosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for NERV and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NERV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NERV vs. The Competition

MetricMinerva NeurosciencesPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$47.18M$5.62B$4.28B$6.32B
Dividend YieldN/A2.73%5.94%7.81%
P/E Ratio-1.364.93107.9311.93
Price / Sales1.15140.572,986.9453.44
Price / CashN/A18.8321.3322.76
Price / Book-1.804.163.934.67
Net Income-$32.11M$197.05M$121.15M$181.37M
7 Day Performance-8.91%-1.23%4.88%3.53%
1 Month Performance-19.45%-11.57%-5.16%-4.75%
1 Year Performance-26.87%5.32%9.54%5.42%

Minerva Neurosciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RMTI
Rockwell Medical
2.2897 of 5 stars
$1.83
-1.6%
$11.00
+501.1%
+57.6%$52.14M$72.81M-2.08253Short Interest ↓
VTGN
Vistagen Therapeutics
2.0905 of 5 stars
$5.36
+1.1%
$30.00
+459.7%
+14.8%$50.17M$1.11M0.0032News Coverage
Gap Down
HOOK
Hookipa Pharma
2.3252 of 5 stars
$0.59
+1.7%
$5.83
+882.9%
-54.0%$49.82M$14.25M-0.6556Short Interest ↑
Gap Down
RZLT
Rezolute
2.3809 of 5 stars
$1.35
+1.5%
$9.00
+566.7%
-51.8%$49.72MN/A-1.3547News Coverage
Positive News
DNTH
Dianthus Therapeutics
2.5153 of 5 stars
$13.05
+0.4%
N/AN/A$49.46MN/A0.00N/AInsider Buying
News Coverage
CLSD
Clearside Biomedical
2.0324 of 5 stars
$0.86
+1.2%
$5.60
+551.2%
-23.0%$53.35M$1.33M-1.4636Analyst Report
Short Interest ↑
News Coverage
Gap Down
MEIP
MEI Pharma
2.256 of 5 stars
$7.34
-1.1%
$40.00
+445.0%
-9.3%$48.88M$40.70M-1.33102Analyst Report
Analyst Revision
IPA
ImmunoPrecise Antibodies
2.1741 of 5 stars
$1.94
-4.0%
$8.00
+312.4%
-54.1%$48.60M$15.61M-3.08102Positive News
SLS
SELLAS Life Sciences Group
2.0506 of 5 stars
$1.71
+11.8%
$5.50
+221.6%
-18.8%$48.48M$1M-1.1017Positive News
VTVT
vTv Therapeutics
1.7645 of 5 stars
$0.45
flat
$6.00
+1,223.3%
-50.7%$47.42M$2.02M-1.8913Analyst Report
News Coverage
Positive News

Related Companies and Tools

This page (NASDAQ:NERV) was last updated on 10/2/2023 by MarketBeat.com Staff

My Account -